Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $19,703.28 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.1684
Revenue (TTM): $0.02 M
Dividend Yield: N/A%
ROE: -18.32%
Latest News
-
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure
Wed, Apr 15, 2026 6:20 PM
-
Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's What You Should Know
Fri, Apr 10, 2026 4:00 PM
Key Financials
Financial data not available